CRDA.L vs SCL
CRDA.L: A leading provider of sustainable specialty chemicals and performance ingredients for the beauty, pharmaceutical, and agriculture industries. SCL: Stepan is a global specialty chemical producer providing surfactants and polymer systems essential to consumer products and industrial applications.
Side-by-side fundamentals
| Metric | CRDA.L | SCL | Edge |
|---|---|---|---|
| Price | £33.38 | $61.04 | |
| Market cap as of 2026-08-03 (share count; price 2026-10-08) | n/a | $1.4B | |
| P/E FY to 2025-12-31, filed 2026-03-16 | 75.18 | n/a | |
| Net margin | +3.8% | +2.0% | CRDA.L higher |
| Gross margin | +43.9% | +11.6% | CRDA.L higher |
| Operating margin FY2025, SEC XBRL | n/a | +3.4% | |
| ROE | +2.9% | +3.8% | SCL higher |
| ROA FY2025, SEC XBRL | n/a | +2.0% | |
| Debt / equity as of 2026-09-02 | n/a | 0.53 | |
| Revenue growth (YoY) as of 2026-09-02 | n/a | +7.6% | |
| Revenue CAGR (3y) SEC XBRL | n/a | -5.6% | |
| Dividend yield as of 2026-09-02 | n/a | +2.6% | |
| Dividend streak (yrs) SEC XBRL | n/a | 16 | |
| Beta as of 2026-09-02 | n/a | 0.89 | |
| 1-year return | +16.2% | +25.1% | SCL higher |
Fundamentals: SEC XBRL company filings and annual report filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-07.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.